UPMC Physician Resources

Take the CME Evaluation

Should Most Older Adults Be on Lipid Lowering Drug Therapy?

UPMC’s Dr. Lewis Kuller presents on the prevention of coronary heart disease. He reviews statistics from the CDC, approaches to preventing coronary heart disease, stating therapy, and recommendations for risk assessment.

Educational objectives:

Upon completion of this activity, participants should be able to:

  • Evaluate and understand guidelines for treatment of hyperlipidemia.
  • Evaluate the relationship between coronary artery calcium, risk scores, and incident coronary heart disease.
  • Identify the complications of statin therapy, especially effects on exercise and diabetes.
  • Discuss and evaluate the solutions to nonadherence to statin therapy.
  • Recognize the potential use of new lipid lowering PCSK inhibitors in treating hyperlipidemia.

Reading Resources:

  1. Goldstein  JL, et  al.  A century of cholesterol  and  coronaries:  From  plaques  to  genes  to statins.  Cell 2015;161:161-72
  2. Mozaffarian  D, et al. Heart disease and stroke statistics-2016 update:  A report from the American Heart Association.  Circulation 2015;133:e38-360.
  3. Stamler J, et al.  Low  Risk-Factor  Profile  and  Long-term  Cardiovascular  and  Noncardiovascular  Mortality  and  Life Expectancy:   Findings  for 5 Large  Cohorts  of Young  Adult and Middle-Aged Men  and Women. JAMA. 1999;282(21):2012-2018

Disclosures:

Dr. Kuller has reported no relevant relationships with proprietary entities producing health care goods or services.

All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above.  No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEU) which are equivalent to .75 contact hour.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

ABIM MOC Part 2 Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

To receive your ABIM MOC Part 2 credit, you will need to complete the post-test and evaluation process and provided your date of birth and ABIM number, along with the other required fields.

Release Date: 4/3/2017 | Last Modified On: 4/3/2017 | Expires: 4/3/2020

Presenter

Lewis Kuller, MD, DrPH

Lewis  Kuller, MD, DrPH Professor and past chair of the Department of Epidemiology at the University of Pittsburgh Graduate School of Public Health (GSPH)
View Full Profile